Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of early administration of recombinant
human erythropoietin on long-term neurological outcome after severe traumatic brain injury.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Claudia Sue Robertson
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)